首页> 美国卫生研究院文献>Molecules >Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery
【2h】

Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery

机译:组胺受体的分子建模 - 药物发现的最近进步

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The recent developments of fast reliable docking, virtual screening and other algorithms gave rise to discovery of many novel ligands of histamine receptors that could be used for treatment of allergic inflammatory disorders, central nervous system pathologies, pain, cancer and obesity. Furthermore, the pharmacological profiles of ligands clearly indicate that these receptors may be considered as targets not only for selective but also for multi-target drugs that could be used for treatment of complex disorders such as Alzheimer’s disease. Therefore, analysis of protein-ligand recognition in the binding site of histamine receptors and also other molecular targets has become a valuable tool in drug design toolkit. This review covers the period 2014–2020 in the field of theoretical investigations of histamine receptors mostly based on molecular modeling as well as the experimental characterization of novel ligands of these receptors.
机译:最近的快速可靠对接,虚拟筛选和其他算法的发展产生了发现许多组胺受体的许多新型配体,可用于治疗过敏性炎症障碍,中枢神经系统病理,疼痛,​​癌症和肥胖症。此外,配体的药理学谱清楚地表明这些受体可能被认为是不仅适用于选择性的靶标,而且对于可用于治疗诸如阿尔茨海默病等复杂疾病的多目标药物。因此,分析组胺受体的结合位点中的蛋白质 - 配体识别,以及其他分子靶标在药物设计工具包中成为一个有价值的工具。本综述涵盖了本组胺受体的理论研究领域的2014 - 2012年期间主要基于分子建模以及这些受体的新配体的实验表征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号